Diagnostic and Therapeutic Advances of RNAs in Precision Medicine of Gastrointestinal Tumors

被引：0
|
作者：
Liu, Runhan [1 ,2 ,3 ]
Zhou, Jiaxin [4 ,5 ]
Chen, Xiaochen [4 ]
Zhang, Jie [4 ,5 ]
Chen, Qunzhi [4 ]
Liu, Xiaoming [1 ,2 ]
Yao, Kunhou [1 ,2 ]
机构：
[1] Henan Univ, Huaihe Hosp, Dept Gastrointestinal Surg, Kaifeng 475000, Peoples R China
[2] Henan Univ, Sch Clin Med, Kaifeng 475004, Peoples R China
[3] Univ Technol Sydney, Sch Biomed Engn, Sydney, NSW 2007, Australia
[4] Henan Univ, Sch Life Sci, Kaifeng 475004, Peoples R China
[5] Henan Univ, Sch Pharm, Kaifeng 475004, Peoples R China
来源：
BIOMEDICINES | 2025年 / 13卷 / 01期
基金：
中国国家自然科学基金; 中国博士后科学基金;
关键词：
gastrointestinal tumors; RNA; diagnosis; drug resistance; precision medicine; LONG NONCODING RNA; PANCREATIC-CANCER CELLS; PROGNOSTIC BIOMARKER; POOR-PROGNOSIS; GASTRIC-CANCER; DELIVERY; PROLIFERATION; TUMORIGENESIS; RESISTANCE; CARCINOMA;
D O I：
10.3390/biomedicines13010047
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Gastrointestinal tumors present a significant challenge for precision medicine due to their complexity, necessitating the development of more specific diagnostic tools and therapeutic agents. Recent advances have positioned coding and non-coding RNAs as emerging biomarkers for these malignancies, detectable by liquid biopsies, and as innovative therapeutic agents. Many RNA-based therapeutics, such as small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have entered clinical trials or are available on the market. This review provides a narrative examination of the diagnostic and therapeutic potential of RNA in gastrointestinal cancers, with an emphasis on its application in precision medicine. This review discusses the current challenges, such as drug resistance and tumor metastasis, and highlights how RNA molecules can be leveraged for targeted detection and treatment. Additionally, this review categorizes specific diagnostic biomarkers and RNA therapeutic targets based on tissue type, offering a comprehensive analysis of their role in advancing precision medicine for gastrointestinal tumors.
引用
收藏
页数：22
相关论文
共 50 条
  • [31] Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives
    Zandieh, Mohammad Arad
    Farahani, Melika Heydari
    Rajabi, Romina
    Avval, Shamim Tavakkoli
    Karimi, Kimia
    Rahmanian, Parham
    Razzazan, Mehrnaz
    Javanshir, Salar
    Mirzaei, Sepideh
    Paskeh, Mahshid Deldar Abad
    Salimimoghadam, Shokooh
    Hushmandi, Kiavash
    Taheriazam, Afshin
    Pandey, Vijay
    Hashemi, Mehrdad
    PHARMACOLOGICAL RESEARCH, 2023, 187
  • [32] Advances in transfusion medicine: gastrointestinal bleeding
    Oakland, K.
    Jairath, V.
    Murphy, M. F.
    TRANSFUSION MEDICINE, 2018, 28 (02) : 132 - 139
  • [33] Surgical Pathology of Gastrointestinal Stromal Tumors: Practical Implications of Morphologic and Molecular Heterogeneity for Precision Medicine
    Charville, Gregory W.
    Longacre, Teri A.
    ADVANCES IN ANATOMIC PATHOLOGY, 2017, 24 (06) : 336 - 353
  • [34] Metastatic Liver Disease Associated with Gastrointestinal Stromal Tumors: Controversies in Diagnostic and Therapeutic Approach
    Mastoraki A.
    Toliaki E.
    Chrisovergi E.
    Mastoraki S.
    Papanikolaou I.S.
    Danias N.
    Smyrniotis V.
    Arkadopoulos N.
    Journal of Gastrointestinal Cancer, 2015, 46 (3) : 237 - 242
  • [35] DIAGNOSTIC ADVANCES IN GASTROINTESTINAL ROENTGENOLOGY - REPLY
    BERRIDGE, FR
    BRITISH JOURNAL OF RADIOLOGY, 1955, 28 (332): : 439 - 439
  • [36] THERAPEUTIC ADVANCES IN GASTROINTESTINAL DISORDERS IN THE ELDERLY
    OTTE, M
    ZEITSCHRIFT FUR GERONTOLOGIE, 1987, 20 (01): : 13 - 16
  • [37] MGMT deficiency distinguishes pancreatic endocrine tumors from gastrointestinal and pulmonary carcinoid tumors: Diagnostic and therapeutic implications
    Redston, M.
    Hornick, J. L.
    LABORATORY INVESTIGATION, 2007, 87 : 290A - 290A
  • [38] MGMT deficiency distinguishes pancreatic endocrine tumors from gastrointestinal and pulmonary carcinoid tumors: Diagnostic and therapeutic implications
    Redston, M.
    Hornick, J. L.
    MODERN PATHOLOGY, 2007, 20 : 290A - 290A
  • [39] Acute myeloid leukemia in the era of precision medicine:recent advances in diagnostic classification and risk stratification
    Rina Kansal
    Cancer Biology & Medicine, 2016, (01) : 41 - 54
  • [40] A precision medicine framework for brain tumors
    Califano, Andrea
    CANCER RESEARCH, 2015, 75
12345